Below are the most recent publications written about "Cell Proliferation" by people in Profiles.
-
Chuang TD, Wiseman A, Alfaro G, Rysling S, Ton N, Baghdasarian D, Khorram O. Transcriptomic and functional analysis of fibroid extracellular vesicles. Clin Sci (Lond). 2026 May 20; 140(5):805-824.
-
Tiwari R, Delossantos J, Ghali ENHK, Chavez LA, Chaudhari VS, Han S, Chauhan SC, Yallapu MM. Biodegradable PCL-PLGA Electrospun Nanofibers for Localized Cancer Therapy. ACS Appl Bio Mater. 2026 May 18; 9(10):4579-4593.
-
Ma X, Nettleford SK, Tian Y, Dawany N, Kondo A, Li Y, Maurer K, Karakasheva TA, Shraim R, Williams PA, Parham LR, Simon LA, Danan CH, Conrad MA, Piccoli DA, Devoto M, Romberg N, Sullivan KE, Kaestner KH, Kelsen JR, Hamilton KE. TNFSF13 insufficiency disrupts human colonic epithelial cell growth and associated B cell dynamics. J Clin Invest. 2026 Apr 01; 136(7).
-
Adeyika TA, Datturgi A, Ettinoffe Y, Ghosh S, Albanese C, Kwabi-Addo B. Epigenetic dysregulation and biological function of PDX1 in prostate cancer. Oncotarget. 2026 Mar 31; 17(1):157-172.
-
Liu W, Mousa AAK, Dayer G, Hopkins AM, Campbell M, Mao Y, Jiang ZH, Lees SJ, Ramachandran R, Hou J. Urea-based lysophosphatidic acid receptor 1 antagonists as potential migrastatics for triple-negative breast cancer. Bioorg Chem. 2026 07 05; 175:109807.
-
Gutierrez DA, Robles-Escajeda E, Lopez-Saenz JA, Kirken RA, Borrego EA, Betancourt AP, Nair S, Roy S, Varela-Ramirez A, Aguilera RJ. Discovery of Two Novel Pyrazole Derivatives as Anticancer Agents Targeting Tubulin Polymerization and MAPK Signaling Pathways. Oncol Res. 2026; 34(4):14.
-
Rasafar N, Sanchez-Michael LA, Torres A, Andujo LA, Gutierrez DA, Varela-Ramirez A, Aguilera RJ, Noveron JC. Novel anticancer alkyl pyridinium derivative exhibits antiproliferative activity via G0/G1 cell cycle arrest and apoptosis activation in triple-negative breast cancer cells. Bioorg Med Chem. 2026 Jun; 137:118638.
-
Sidhu RS, Ramar V, Safir T, Jones T, Guo S, Wang G, Liu M. Rap1b promotes glioma growth and stemness via regulation of Notch1 and VEGFR2 signaling pathways. Cell Signal. 2026 Jul; 143:112457.
-
Gao Y, Chen W, Zarogoulidis P, Yallapu MM, Nikolic MV, Vaishnani DK, Zheng J, Nedeljkovic N, Ye K, Guo Y, Xu Q. Multiomics and experimental validation reveal theophylline's mechanism targeting IL1A/ACTB/TLR4 and identify synergistic drugs in hepatocellular carcinoma. J Pharmacol Exp Ther. 2026 Mar; 393(3):103836.
-
Ahmad M, Alvi SS, Ahsan H, Perez C, Massey A, Kashyap VK, Chauhan N, Anning E, Tripathi MK, Kim DJ, Sahoo N, Oraby T, Yallapu MM, Khan MM, Sebastian MM, Chauhan SC, Hafeez BB. Ubiquitination of Oncogenic Mutant p53 via Attenuation of Ribosome Biogenesis Machinery Effectively Inhibits Pancreatic Tumor Growth. Mol Cancer Ther. 2026 Feb 04; 25(2):257-271.